Hiromichi Ebi

EGFR-Mediated Reactivation of MAPK Signaling Contributes to Insensitivity of <i>BRAF</i> -Mutant Colorectal Cancers to RAF Inhibition with Vemurafenib

Ryan B. Corcoran, Hiromichi Ebi, Alexa B. Turke et al. · Cancer Discovery · 2012 · 1K citations · Full text

Medicine, Oncology, Pharmacology +17

Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: a JSMO–ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS

Takayuki Yoshino, Dirk Arnold, Hiroya Taniguchi et al. · Annals of Oncology · 2017 · 592 citations · Full text

Medicine, Oncology, Surgery +16

Therapeutic strategies to overcome crizotinib resistance in non-small cell lung cancers harboring the fusion oncogene EML4-ALK

Ryohei Katayama, Tahsin M. Khan, Cyril H. Benes et al. · Proceedings of the National Academy of Sciences · 2011 · 540 citations · Full text

Medicine, Oncology, Pharmacology +16

A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic response

Chen Zhao, Katherine A. Cheng, Zandra E. Walton et al. · Nature · 2012 · 451 citations

Medicine, Genetics, Oncology +10

Synthetic Lethal Interaction of Combined BCL-XL and MEK Inhibition Promotes Tumor Regressions in KRAS Mutant Cancer Models

Ryan B. Corcoran, Katherine A. Cheng, Aaron N. Hata et al. · Cancer Cell · 2012 · 379 citations · Full text

Medicine, Cancer Biology, Oncology +17